KY ® Duration ® Gel for Him

Manufacturer
RB Health (US) LLC
Effective date
2026-03-11
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
monthly-update
Hydrated at
2026-06-03 17:58:44

Label at a glance#

ProductKY Duration for Him
Active ingredientBENZOCAINE
Label structure11 sections

Indications and uses

helps in the prevention of premature ejaculation helps in temporarily prolonging the time until ejaculation

Dosage and administration

apply a small amount to the head and shaft of the penis before intercourse, or use as directed by a doctor. Wash product off after intercourse. use only on intact, non-inflamed skin allow gel to dry prior to intercourse not suitable for oral use use as directed, not more than four times per day

Storage and handling

store between 20-25°C (68-77°F) compatible with latex condoms child resistant closure. Instructions for opening are included in the leaflet. read the enclosed leaflet to achieve best results

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Benzocaine USP 7%

Purpose

OTC - PURPOSE SECTION

Male Genital Desensitizer

Uses

INDICATIONS & USAGE SECTION

  • helps in the prevention of premature ejaculation
  • helps in temporarily prolonging the time until ejaculation

Warnings

WARNINGS SECTION

For external use only

Premature ejaculation may be due to a condition requiring medical supervision. If this product, used as directed, does not provide relief, discontinue use and consult a doctor.

SPL UNCLASSIFIED SECTION

Avoid contact with the eyes

If you or your partner develop a rash or irritation, such as burning or itching, discontinue use. If symptoms persist, consult a doctor.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breastfeeding,ask a health professional before use

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If swallowed, get medical help or contact a poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • apply a small amount to the head and shaft of the penis before intercourse, or use as directed by a doctor. Wash product off after intercourse.
  • use only on intact, non-inflamed skin
  • allow gel to dry prior to intercourse
  • not suitable for oral use
  • use as directed, not more than four times per day

Other information

STORAGE AND HANDLING SECTION

  • store between 20-25°C (68-77°F)
  • compatible with latex condoms
  • child resistant closure. Instructions for opening are included in the leaflet.
  • read the enclosed leaflet to achieve best results

Inactive Ingredients

INACTIVE INGREDIENT SECTION

carbomer homopolymer type B, polyethylene glycol

Questions?

OTC - QUESTIONS SECTION

1-800-756-5488

SPL UNCLASSIFIED SECTION

Dist. by:RB Health (US)
Parsippany, NJ 07054-0224

PRINCIPAL DISPLAY PANEL 5.0 mL Can Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

36
pumps

KY ®
EST
1904

duration ®

gel for him

male genital desensitizer
Benzocaine USP 7%

latex condom compatible

don't
stop

36 Pumps 0.16 fl oz (5.0 mL)

PRINCIPAL DISPLAY PANEL 5.0 mL Can Label
PRINCIPAL DISPLAY PANEL 5.0 mL Can Label

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72854-68372854-683-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
51e0dc44-88ce-3088-e063-6294a90a6f7b2d3de38b-4005-40ec-9305-ba688fc678172026-05-15WarningsExact identifier
spl set id: 2d3de38b-4005-40ec-9305-ba688fc67817

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.